Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This is a six week, double blind,placebo controlled study for patients with schizophrenia or schizoaffective disorder treated with an atypical antipsychotic for at least two months. Subjects will be randomized to take armodafinil (Nuvigil) or placebo along with their current antipsychotic and tested at baseline and week 6 for differences in memory, attention and problem-solving ability. Changes in weight during the six week study will also be tracked.
Epistemonikos ID: 1925a6f406126d8943428c694b7d806f211ee6e2
First added on: May 04, 2024